A small molecule that inhibits the evolution of antibiotic resistance

Author:

Carvajal-Garcia Juan1ORCID,Bracey Harrison1,Johnson Anna E1,Hernandez Viera Angel J1,Egli Martin1ORCID,Simsek Esra N1,Jaremba Emily A1,Kim Kwangho2,Merrikh Houra1

Affiliation:

1. Department of Biochemistry, Vanderbilt University , Nashville, TN 37232 , USA

2. Vanderbilt Institute of Chemical Biology, Vanderbilt University , Nashville, TN 37232 , USA

Abstract

Abstract Antibiotic resistance rapidly develops against almost all available therapeutics. Therefore, searching for new antibiotics to overcome the problem of antibiotic resistance alone is insufficient. Given that antibiotic resistance can be driven by mutagenesis, an avenue for preventing it is the inhibition of mutagenic processes. We previously showed that the DNA translocase Mfd is mutagenic and accelerates antibiotic resistance development. Here, we present our discovery of a small molecule that inhibits Mfd-dependent mutagenesis, ARM-1 (anti-resistance molecule 1). We found ARM-1 using a high-throughput, small molecule, in vivo screen. Using biochemical assays, we characterized the mechanism by which ARM-1 inhibits Mfd. Critically, we found that ARM-1 reduces mutagenesis and significantly delays antibiotic resistance development across highly divergent bacterial pathogens. These results demonstrate that the mutagenic proteins accelerating evolution can be directly inhibited. Furthermore, our findings suggest that Mfd inhibition, alongside antibiotics, is a potentially effective approach for prevention of antibiotic resistance development during treatment of infections.

Funder

National Institutes of Health

Bill and Melinda Gates Foundation

Helen Hay Whitney Foundation

Vanderbilt University

Publisher

Oxford University Press (OUP)

Reference71 articles.

1. The antimicrobial resistance crisis: part 1—causes and threats;Ventola;Pharm. Ther.,2015

2. The review on antimicrobial resistance: tackling drug-resistant infections globally;O’Neill;Arch. Pharm. Pract.,2016

3. Antimicrobial resistance: implications and costs;Dadgostar;Infect. Drug Resist.,2019

4. The antibacterial research and development pipeline needs urgent solutions;Beyer;ACS Infect. Dis.,2020

5. Targets for combating the evolution of acquired antibiotic resistance;Culyba;Biochemistry,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3